Mayelana nenkampani yethuUkubuka Konke Kokwelashwa Kwe-CAR-T

I-CAR-T Therapy, efushanisiwe nelithi Chimeric Antigen Receptor T-Cell Immunotherapy, iyindlela yokwelapha izakhi zofuzo ethuthukisiwe ehilela ukuguqula izakhi zofuzo zamaseli e-T esiguli ukuze ihlose futhi ibhubhise amaseli omdlavuza. Ngokungafani nemithi yendabuko, ukwelashwa kwe-CAR-T kwenzelwe isiguli ngasinye futhi kudinga ukuqoqa amaseli e-T egazini lesiguli ngaphambi kokuwabuyisela emzimbeni ngemva kobunjiniyela bezakhi zofuzo.

Hlola Izici

Izinkomba ze-CAR-T

● I-B-cell acute lymphoblastic leukemia

● I-myeloma eminingi

● I-leukemia yama-lymphocytic engapheli

● I-Non-Hodgkin lymphoma

● I-lymphoma enkulu ye-B-cell esakazekayo

● I-SLE (i-Systemic Lupus Erythematosus)

Ukusebenza kahle kakhulu kwezokwelapha kwe-CAR-T

Izinkomba ze-CD19+20CAR-T: Iziguli ezine-B-cell non-Hodgkin's lymphoma

Izinga le-CR lenyanga eyodwa	Izinga le-PR lenyanga eyodwa	Isilinganiso se-OR senyanga eyodwa	I-CRS≥3	I-CRES≥3
71.95% (59/82)	25.6（21/82）	97.55（80/82）	12.19% (10/82)	0

Izinkomba ze-CD19+22CAR-T: Ukwelashwa kweziguli ezine-CD19 eziphinde zabuyela emuva futhi ezingasabeli kahle i-B-lymphocytic leukemia

Izinga le-CR lenyanga eyodwa	Izinga le-PR lenyanga eyodwa	Isilinganiso se-OR senyanga eyodwa	I-CRS≥3	I-CRES≥3
92.1%（35/38）	7.9%（3/38）	100% (38/38)	15.79% (6/38)	0

Izinkomba ze-BCMACAR-T: Ukwelashwa kwe-myeloma eminingi ephinde yabuya futhi engaphikisi

Izinga le-CR lenyanga eyodwa	Izinga le-PR lenyanga eyodwa	Isilinganiso se-OR senyanga eyodwa	I-CRS≥3	I-CRES≥3
72.41% (21/29)	27.59%（8/29）	100% (29/29)	6.9% (2/29)	0

Kungani Kufanele Ukhethe Thina?

Izinzuzo Zethu

●Ukwelashwa Okuqondene Nakho: Senza ngokwezifiso ukwelashwa kwe-CAR-T kwesiguli ngasinye, siqinisekisa ukwelashwa okuqondiwe futhi okuphumelelayo.

●Izinketho Ezihlukahlukene Zokuhlonza: Imikhiqizo yethu ye-CAR-T inikeza izinketho eziningi ezihlosiwe, okuhlanganisa i-CD7, i-CD19, i-CD20, i-CD22, kanye ne-BCMA, okunikeza inzuzo yezinketho zokwelapha ezenzelwe wena iziguli.

●Ubuchwepheshe Obusezingeni Eliphezulu: Ukwelashwa kwethu kwe-CAR-T kusebenzisa intuthuko yakamuva kubunjiniyela bezakhi zofuzo kanye ne-immunotherapy.

●Ukusebenza kahle kwezindleko: Uma kuqhathaniswa neminye imikhiqizo, sinikeza ibhalansi engcono kakhulu phakathi kokuqinisekiswa kwekhwalithi kanye namanani ancintisanayo.

●Ubuchwepheshe Bezokwelapha: Sisekelwa yithimba lodokotela abanolwazi nabacwaningi, sinikeza ukunakekelwa kwekhwalithi ephezulu kanye nokusekelwa kuyo yonke inqubo yokwelashwa.

●Indlela Ephelele: Sinikeza ukunakekelwa okuphelele, kusukela ekuhlolweni kwesiguli kuya ekuphathweni kokwelashwa kanye nokulandelela, siqinisekisa imiphumela emihle kakhulu.